Publications by authors named "F Bossa"

Claim this Profile
W
When to Switch to Subcutaneous Infliximab? The RE-WATCH Multicenter Study.
Lorenzo Bertani, Davide Giuseppe Ribaldone, Fabrizio Bossa, Maria Guerra, Monica Annese

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: "Early Switching to Subcutaneous Infliximab as a Pragmatic Strategy for Optimized Inflammatory Bowel Disease Care".
Lorenzo Bertani, Davide Giuseppe Ribaldone, Fabrizio Bossa, Maria Guerra, Monica Annese

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning approach and internet of things technologies to unravel the complex interaction between microbiome-metabolome in inflammatory bowel disease: a new frontier in precision medicine.
Orazio Palmieri, Anna Lucia Cannarozzi, Anna Latiano, Luca Massimino, Fabrizio Bossa

Gut Pathog· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Italian-Telemedicine Satisfaction Questionnaire in inflammatory bowel disease patients in Italy.
Giuseppina Martino, Alessio Lo Cascio, Mattia Bozzetti, Stefano Martino, Gabriele Rumi, Fabrizio Bossa

Minerva Gastroenterol (Torino)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease.
Francesca Tavano, Orazio Palmieri, Maria Latiano, Domenica Gioffreda, Tiziana Latiano, Fabrizio Bossa

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis